Corise Opthocare GP (5ml) is a prescription-only veterinary dual-action ophthalmic suspension formulated to simultaneously treat acute bacterial eye infections and severe localized tissue inflammation in dogs and cats. The high-potency formulation combines two active pharmaceutical ingredients: Gatifloxacin (0.3% w/v) and Prednisolone Acetate IP (1.0% w/v), preserved with Benzalkonium Chloride IP (0.005%) to guarantee solution sterility throughout the treatment course.

Gatifloxacin is an advanced, fourth-generation broad-spectrum fluoroquinolone antibiotic. It exerts rapid bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, effectively blocking bacterial DNA replication and clearing stubborn pathogens. Complementing this, Prednisolone Acetate is a potent corticosteroid that suppresses the inflammatory response at a cellular level, delivering rapid relief from swelling, heat, redness, and allergic irritation. In veterinary ophthalmology, Opthocare GP is a premier option for managing non-ulcerative conjunctivitis, keratitis, scleritis, and anterior uveitis.

Critical Medical Warning: Corticosteroid-containing eye medications like Opthocare GP must never be administered if a corneal ulcer, scratch, or abrasion is present. Steroids delay corneal healing and can lead to rapid corneal melting, perforation, or permanent blindness. A veterinarian must perform a fluorescein stain test to confirm an intact cornea before using this product.